Reimagining Eyesight: The Future of Ophthalmic Technology Revealed

Send us a text

In this episode of the Life Science Success Podcast my guest is Thomas Ruggia, the President and CEO of Samsara Vision, a specialty medical device company focused on developing innovative implantable ophthalmic technologies to improve vision for individuals with untreatable retinal disorders. With extensive experience in ophthalmology from his previous roles at Johnson & Johnson and Alcon, Thomas brings a wealth of knowledge and passion to Samsara Vision's mission of rejuvenating eyesight and helping people reconnect with the world around them.

00:00 Introduction to Life Science Success Podcast
00:34 Meet Thomas Ruggia: CEO of Samsara Vision
01:38 Thomas Ruggia's Journey into the Medical Device Industry
03:14 Career Highlights: Alcon and Johnson & Johnson
11:49 Samsara Vision's Flagship Product: SING IMT
17:31 Future of Ophthalmic Devices and Treatments
27:26 Personal Insights and Leadership Advice
31:08 Global Perspective and Concerns
34:46 Excitement for Future Technologies
40:19 Conclusion and Farewell